TGA Approval

DATROWAY datopotamab deruxtecan 100 mg powder for injection vial (444066)

ARTG ID

444066

ARTG Name

DATROWAY datopotamab deruxtecan 100 mg powder for injection vial

Sponsor

AstraZeneca Pty Ltd

ARTG Date

May 20, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ASTRAZENECA PTY LTD

Ingredient Name

datopotamab deruxtecan

Empowering clinical research with data-driven insights and AI-powered tools.

DATROWAY datopotamab deruxtecan 100 mg powder for injection vial (444066) - TGA 批准文号 | MedPath